# Sapropterin as a Treatment for Autistic Disorder

> **NCT00850070** · PHASE2 · COMPLETED · sponsor: **The Children's Health Council** · enrollment: 46 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** sapropterin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00850070
- **Lead sponsor:** The Children's Health Council
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-08
- **Final completion:** 2011-10
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00850070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00850070, "Sapropterin as a Treatment for Autistic Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00850070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*